Drug Shortage Report for JAMP-FLUOXETINE
Report ID | 189268 |
Drug Identification Number | 02401894 |
Brand name | JAMP-FLUOXETINE |
Common or Proper name | Fluoxetine Capsules BP (as fluoxetine hydrochloride) |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | FLUOXETINE |
Strength(s) | 10MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-04-11 |
Estimated end date | 2023-05-30 |
Actual end date | 2023-05-05 |
Shortage status | Resolved |
Updated date | 2023-05-05 |
Company comments | Increase in demand. Under allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-04-11 | English | Compare |
v2 | 2023-04-11 | English | Compare |
v3 | 2023-04-11 | French | Compare |
v4 | 2023-04-12 | English | Compare |
v5 | 2023-05-05 | English | Compare |
v6 | 2023-05-05 | French | Compare |
Showing 1 to 6 of 6